News
UBTech’s UWorld U1 tests demand for humanoid robots at home
The series has drawn over 13,000 orders, as UBTech tries to move humanoid robots beyond industrial use and into households.
5 mins read
Cheng Zi
Cheng Zi is based in China, covering technology- and business-related events. She works with her colleagues at 36Kr Global to provide coverage in both English and Chinese.
The company has cleared Chapter 18C thresholds, but IPO pricing will test investor confidence in upstream robotics suppliers.
Dr H joins a growing group of brands trying to make health management more personal, wearable, and actionable.
It has raised its revenue targets, betting that stronger models will lift its cloud business.
Smart driving, customized vehicles, and AI-powered operations must work together to make driverless mobility commercially viable.
Data standards and real-world deployment remain key barriers to progress.
OBSBot found its footing with webcams, then used that cash flow to invest in a broader smart imaging ecosystem.
A small float helped amplify the stock’s swing, turning its IPO into a test of investor sentiment.
The drug developer has no approved products or revenue yet, but the IPO could extend its cash runway by nearly six years.